Items where authors include "Meads, D.M."

Article

Jayne, D. orcid.org/0000-0002-8725-3283, Croft, J. orcid.org/0000-0001-7586-3394, Corrigan, N. et al. (99 more authors) (2025) Intraoperative fluorescence angiography with indocyanine green to prevent anastomotic leak in rectal cancer surgery (IntAct): an unblinded randomised controlled trial. The Lancet Gastroenterology & Hepatology, 10 (9). pp. 806-817. ISSN 2468-1253

Johnson, M.J., Wright-Hughes, A. orcid.org/0000-0001-8839-6756, McNaught, E. et al. (14 more authors) (2025) Clinical and cost-effectiveness of Cancer Patients’ Needs Assessment in Primary Care (CANAssess2): A pragmatic cluster randomised controlled trial. The Lancet Primary Care. ISSN 3050-5143 (In Press)

O’Dwyer, J.L., Bryant, L.D., Hulme, C. et al. (2 more authors) (2024) Adapting the EQ-5D-3L for adults with mild to moderate learning disabilities. Health and Quality of Life Outcomes, 22. 37. ISSN 1477-7525

Downey, C.L. orcid.org/0000-0001-9818-8002, Bainbridge, J., Jayne, D.G. orcid.org/0000-0002-8725-3283 et al. (1 more author) (2023) Impact of in-hospital postoperative complications on quality of life up to 12 months after major abdominal surgery. British Journal of Surgery, 110 (9). pp. 1206-1212. ISSN 0007-1323

Winterbottom, A.E., Gavaruzzi, T., Mooney, A. et al. (8 more authors) (2016) Patient Acceptability of the Yorkshire Dialysis Decision Aid (YoDDA) Booklet: A Prospective Non-Randomized Comparison Study Across 6 Predialysis Services. Peritoneal Dialysis International, 36 (4). pp. 374-381. ISSN 0896-8608

McKenna, S.P., Ratcliffe, J., Meads, D.M. et al. (1 more author) (2008) Development and validation of a preference based measure derived from the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) for use in cost utility analyses. Health and Quality of Life Outcomes, 6. 65. ISSN 1477-7525

Proceedings Paper

Danson, S., Collinson, M., Plummer, E.R. et al. (17 more authors) (2025) Comparison of 1 year versus minimum 2 years of anti-PD1-based immunotherapy as first-line treatment for metastatic melanoma: Results of the DANTE phase III trial. In: Journal of Clinical Oncology. 2025 ASCO Annual Meeting II, 30 May - 03 Jun 2025, Chicago, USA. American Society of Clinical Oncology (ASCO) .